Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Ars Pharmaceuticals Inc (SPRY)

Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday Motley Fool - Wed Sep 20, 2023

The company received a Complete Response Letter from the FDA regarding its lead therapy.

SPRY : 8.80 (-1.46%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire - Tue May 30, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 8.80 (-1.46%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire - Fri May 19, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 8.80 (-1.46%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PR Newswire - Wed May 10, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or the "Company") (NASDAQ: SPRY). Such...

SPRY : 8.80 (-1.46%)
Is IQ Chaikin U.S. Small Cap ETF (CSML) a Strong ETF Right Now? Zacks - Mon Apr 17, 2023

Smart Beta ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 847.38 (-2.96%)
IWM : 203.19 (-1.64%)
IJR : 107.81 (-1.44%)
IMVT : 28.39 (-3.96%)
SPRY : 8.80 (-1.46%)
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar? Zacks - Wed Apr 12, 2023

Style Box ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 847.38 (-2.96%)
IWM : 203.19 (-1.64%)
IJR : 107.81 (-1.44%)
IMVT : 28.39 (-3.96%)
SPRY : 8.80 (-1.46%)
Is IQ Chaikin U.S. Small Cap ETF (CSML) a Strong ETF Right Now? Zacks - Mon Feb 13, 2023

Smart Beta ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 847.38 (-2.96%)
IWM : 203.19 (-1.64%)
IJR : 107.81 (-1.44%)
IMVT : 28.39 (-3.96%)
SPRY : 8.80 (-1.46%)
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar? Zacks - Wed Feb 8, 2023

Style Box ETF report for CSML

CSML : 34.95 (+0.71%)
SMCI : 847.38 (-2.96%)
IWM : 203.19 (-1.64%)
IJR : 107.81 (-1.44%)
IMVT : 28.39 (-3.96%)
SPRY : 8.80 (-1.46%)

Barchart Exclusives

Is This Dividend Stock a Good Buy to Take Advantage of a Bitcoin Rally? Barchart - Thu May 23, 6:30PM CDT
Discover how CME Group's rumored move into spot Bitcoin trading, along with its solid financial results and growing dividends, could make it a smart investment choice during the crypto boom. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot